Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Plasmids"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review Article
Yersinia pestis antibiotic resistance: a systematic review
Chen Lei, Suresh Kumar
Osong Public Health Res Perspect. 2022;13(1):24-36.   Published online February 18, 2022
DOI: https://doi.org/10.24171/j.phrp.2021.0288
  • 10,434 View
  • 308 Download
  • 14 Web of Science
  • 17 Crossref
AbstractAbstract PDF
Yersinia pestis, the cause of plague and a potential biological weapon, has always been a threatening pathogen. Some strains of Y. pestis have varying degrees of antibiotic resistance. Thus, this systematic review was conducted to alert clinicians to this pathogen’s potential antimicrobial resistance. A review of the literature was conducted for experimental reports and systematic reviews on the topics of plague, Y. pestis, and antibiotic resistance. From 1995 to 2021, 7 Y. pestis isolates with 4 antibiotic resistance mechanisms were reported. In Y. pestis 17/95, 16/95, and 2180H, resistance was mediated by transferable plasmids. Each plasmid contained resistance genes encoded within specific transposons. Strain 17/95 presented multiple drug resistance, since plasmid 1202 contained 10 resistance determinants. Strains 16/95 and 2180H showed single antibiotic resistance because both additional plasmids in these strains carried only 1 antimicrobial determinant. Strains 12/87, S19960127, 56/13, and 59/13 exhibited streptomycin resistance due to an rpsl gene mutation, a novel mechanism that was discovered recently. Y. pestis can acquire antibiotic resistance in nature not only via conjugative transfer of antimicrobial-resistant plasmids from other bacteria, but also by gene point mutations. Global surveillance should be strengthened to identify antibiotic-resistant Y. pestis strains by whole-genome sequencing and drug susceptibility testing.

Citations

Citations to this article as recorded by  
  • Seek and you shall find: Yersinia enterocolitica in Ireland’s drinking water
    James Powell, Maureen Daly, Nuala H. O’Connell, Colum P. Dunne
    Irish Journal of Medical Science (1971 -).2024; 193(4): 1885.     CrossRef
  • A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague
    Xiao Guo, Youquan Xin, Zehui Tong, Shiyang Cao, Yuan Zhang, Gengshan Wu, Hongyan Chen, Tong Wang, Yajun Song, Qingwen Zhang, Ruifu Yang, Zongmin Du, Gregory P. Priebe
    PLOS Pathogens.2024; 20(3): e1012129.     CrossRef
  • Interaction between Yersinia pestis Ail Outer Membrane Protein and the C-Terminal Domain of Human Vitronectin
    Laurine Vasseur, Florent Barbault, Antonio Monari
    The Journal of Physical Chemistry B.2024; 128(16): 3929.     CrossRef
  • Integrated Computational Analysis of Physicochemical Features, Biological Properties, Kinase Target Prediction and Biotransformation Pathways in Drug Discovery
    Mohamed Sabri Bensaad, Dhiya Eddine Bensaad, Mohamed Amine Kahoul, Dania S. Waggas, Roua S. Baty, Rokayya Sami, Hamsa Jameel Banjer, Siraj B. Alharthi, Ruqaiah I. Bedaiwi, Zeyad M. Alharbi, Mohammad A. Alanazi, Nouf H. Alsubhi, Ashwaq M. Al-Nazawi, Nada A
    International Journal of Pharmacology.2024; 20(5): 748.     CrossRef
  • Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision
    Maria Vittoria Ristori, Valerio Guarrasi, Paolo Soda, Nicola Petrosillo, Fiorella Gurrieri, Umile Giuseppe Longo, Massimo Ciccozzi, Elisabetta Riva, Silvia Angeletti
    Genes.2024; 15(7): 908.     CrossRef
  • Screening of promising molecules against potential drug targets in Yersinia pestis by integrative pan and subtractive genomics, docking and simulation approach
    Lei Chen, Lihu Zhang, Yanping Li, Liang Qiao, Suresh Kumar
    Archives of Microbiology.2024;[Epub]     CrossRef
  • Plasmonic-Enhanced Colorimetric Lateral Flow Immunoassays Using Bimetallic Silver-Coated Gold Nanostars
    Supriya Atta, Yuanhao Zhao, Sebastian Sanchez, Deven Seedial, Jasmine Pramila Devadhasan, Alexander Jarrett Summers, Marcellene A. Gates-Hollingsworth, Kathryn J Pflughoeft, Jian Gu, Douglas C. Montgomery, David P. AuCoin, Frederic Zenhausern, Tuan Vo-Din
    ACS Applied Materials & Interfaces.2024; 16(40): 54907.     CrossRef
  • Madagascar’s Plague: One Health Research Aims to Slow Its Spread
    Wendee Nicole
    Environmental Health Perspectives.2024;[Epub]     CrossRef
  • The Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice
    Emily K. Hendrix, Jian Sha, Paul B. Kilgore, Blake H. Neil, Atul K. Verma, Ashok K. Chopra
    Vaccines.2024; 12(12): 1361.     CrossRef
  • Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
    Moshe Aftalion, Avital Tidhar, Yaron Vagima, David Gur, Ayelet Zauberman, Tzvi Holtzman, Arik Makovitzki, Theodor Chitlaru, Emanuelle Mamroud, Yinon Levy
    Vaccines.2023; 11(3): 581.     CrossRef
  • Antibiotic resistance in Neisseria gonorrhoeae: broad-spectrum drug target identification using subtractive genomics
    Umairah Natasya Mohd Omeershffudin, Suresh Kumar
    Genomics & Informatics.2023; 21(1): e5.     CrossRef
  • Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague
    Sergei S. Biryukov, Hua Wu, Jennifer L. Dankmeyer, Nathaniel O. Rill, Christopher P. Klimko, Kristi A. Egland, Jennifer L. Shoe, Melissa Hunter, David P. Fetterer, Ju Qiu, Michael L. Davies, Christoph L. Bausch, Eddie J. Sullivan, Thomas Luke, Christopher
    Antibodies.2023; 12(2): 33.     CrossRef
  • New Bacteriophages with Podoviridal Morphotypes Active against Yersinia pestis: Characterization and Application Potential
    Tamar Suladze, Ekaterine Jaiani, Marina Darsavelidze, Maia Elizbarashvili, Olivier Gorge, Ia Kusradze, Tamar Kokashvili, Nino Lashkhi, George Tsertsvadze, Nino Janelidze, Svetlana Chubinidze, Marina Grdzelidze, Shota Tsanava, Eric Valade, Marina Tediashvi
    Viruses.2023; 15(7): 1484.     CrossRef
  • Characterization of Mu-Like Yersinia Phages Exhibiting Temperature Dependent Infection
    Biao Meng, Zhizhen Qi, Xiang Li, Hong Peng, Shanzheng Bi, Xiao Wei, Yan Li, Qi Zhang, Xiaoqing Xu, Haihong Zhao, Xiaoyan Yang, Changjun Wang, Xiangna Zhao, Olaya Rendueles
    Microbiology Spectrum.2023;[Epub]     CrossRef
  • Ancient Yersinia pestis genomes lack the virulence-associated Ypf Φ prophage present in modern pandemic strains
    Joanna H. Bonczarowska, Julian Susat, Ben Krause-Kyora, Dorthe Dangvard Pedersen, Jesper Boldsen, Lars Agersnap Larsen, Lone Seeberg, Almut Nebel, Daniel Unterweger
    Proceedings of the Royal Society B: Biological Sci.2023;[Epub]     CrossRef
  • A situation analysis of the current plague outbreak in the Demographic Republic of Congo and counteracting strategies – Correspondence
    Ranjit Sah, Abdullah Reda, Rachana Mehta, Ranjan K. Mohapatra, Kuldeep Dhama
    International Journal of Surgery.2022; 105: 106885.     CrossRef
  • Antimicrobial resistance in Klebsiella pneumoniae: identification of bacterial DNA adenine methyltransferase as a novel drug target from hypothetical proteins using subtractive genomics
    Umairah Natasya Mohd Omeershffudin, Suresh Kumar
    Genomics & Informatics.2022; 20(4): e47.     CrossRef
Original Article
Cell Death Mechanisms in Esophageal Squamous Cell Carcinoma Induced by Vesicular Stomatitis Virus Matrix Protein
Yousef Douzandegan, Alireza Tahamtan, Zahra Gray, Hadi Razavi Nikoo, Alijan Tabarraei, Abdolvahab Moradi
Osong Public Health Res Perspect. 2019;10(4):246-252.   Published online August 31, 2019
DOI: https://doi.org/10.24171/j.phrp.2019.10.4.08
  • 7,314 View
  • 154 Download
  • 9 Crossref
AbstractAbstract PDF
Objectives

Vesicular stomatitis virus (VSV) is under development as an oncolytic virus due to its preferential replication in cancer cells and oncolytic activity, however the viral components responsible have not yet been determined. In this study the effects of VSV wild-type (wt) and M51R-mutant matrix proteins (M51R-mMP) on apoptosis, pyroptosis, necroptosis, and autophagy pathways, in an esophagus cancer cell line (KYSE-30) were investigated.

Methods

The KYSE-30 cells were transfected with pcDNA3.1 plasmids encoding wt or M51R-mMP, and apoptosis, pyroptosis, necroptosis, and autophagy were evaluated 48 and 72 hours after transfection.

Results

KYSE-30 cells transfected with VSV wt and M51R-mMPs significantly reduced cell viability to < 50% at 72 hours post-transfection. M51R-MP significantly increased the concentration of caspase-8 and caspase-9 at 48 and 72 hours post-transfection, respectively ( p < 0.05). In contrast, no significant changes were detected following transfection with the VSV wt plasmid. Moreover, VSV wt and M51R-mMP transfected cells did not change the expression of caspase-3. VSV wt and M51R-mMPs did not mMP change caspase-1 expression (a marker of pyroptosis) at 48 and 72 hours post-transfection. However, M51R-mMP and VSV wt transfected cells significantly increased RIP-1 (a marker of necroptosis) expression at 72 hours post-infection ( p < 0.05). Beclin-1, a biomarker of autophagy, was also induced by transfection with VSV wt or M51R-mMPs at 48 hours post-transfection.

Conclusion

The results in this study indicated that VSV exerts oncolytic activity in KYSE-30 tumor cells through different cell death pathways, suggesting that M51R-mMP may potentially be used to enhance oncolysis.

Citations

Citations to this article as recorded by  
  • Evoking pyroptosis with nanomaterials for cancer immunotherapy: Current boom and novel outlook
    Wen-Da Wang, Zhi-Jun Sun
    Nano TransMed.2022; 1(1): 9130001.     CrossRef
  • Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
    Amirhossein Mardi, Anastasia V. Shirokova, Rebar N. Mohammed, Ali Keshavarz, Angelina O. Zekiy, Lakshmi Thangavelu, Talar Ahmad Merza Mohamad, Faroogh Marofi, Navid Shomali, Amir Zamani, Morteza Akbari
    Cancer Cell International.2022;[Epub]     CrossRef
  • Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors
    Qingbo Li, Patrick Kwabena Oduro, Rui Guo, Ruiqiao Li, Ling Leng, Xianbin Kong, Qilong Wang, Long Yang
    Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
  • Live-attenuated poliovirus-induced extrinsic apoptosis through Caspase 8 within breast cancer cell lines expressing CD155
    Hossein Vazeh, Emad Behboudi, Anahita Hashemzadeh-Omran, Abdolvahab Moradi
    Breast Cancer.2022; 29(5): 899.     CrossRef
  • Exogenous expression of both matrix protein and glycoprotein facilitates infectious viral particle production of Borna disease virus 1
    Takehiro Kanda, Madoka Sakai, Akiko Makino, Keizo Tomonaga
    Journal of General Virology .2022;[Epub]     CrossRef
  • La herencia de Prometeo. Las enfermedades ocupacionales en el Corpus Hippocraticum
    César Sierra Martín
    Asclepio.2022; 74(1): p587.     CrossRef
  • Analyses of cell death mechanisms related to amino acid substitution at position 95 in the rabies virus matrix protein
    Isshu Kojima, Fumiki Izumi, Makoto Ozawa, Yoshikazu Fujimoto, Misuzu Okajima, Naoto Ito, Makoto Sugiyama, Tatsunori Masatani
    Journal of General Virology .2021;[Epub]     CrossRef
  • The role of non-apoptotic cell death in the treatment and drug-resistance of digestive tumors
    Yang Yang, LiangLiang Bai, Weiting Liao, Mingyang Feng, Mengxi Zhang, Qiuji Wu, Kexun Zhou, Feng Wen, Wanting Lei, Nan Zhang, Jiaxing Huang, Qiu Li
    Experimental Cell Research.2021; 405(2): 112678.     CrossRef
  • NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-protein
    Zoleikha Mamizadeh, Mohamad Reza Kalani, Masoud Parsania, Mohammad Mehdi Soltan Dallal, Abdolvahab Moradi
    Molecular Therapy - Oncolytics.2021; 23: 593.     CrossRef

PHRP : Osong Public Health and Research Perspectives
TOP